Sanofi consumer health unit seeing intertest ahead of split, Bloomberg says

Buyout firms, including Advent International, Blackstone Group (BX), Bain Capital, CVC Capital Partners, EQT AB and KKR (KKR) have interest in Sanofi’s consumer health division ahead of a potential separation of the business, Dinesh Nair, Swetha Gopinath and Manuel Baigorri of Bloomberg report, citing people familiar with the matter. The unit could be valued at about $20B in any deal, sources told Bloomberg. Advisers to Sanofi have communicated that it’s open to a sale of the consumer health business if it can achieve its desired valuation, the people said. Sanofi may retain a stake in the business as part of any agreement, and deliberations are in the early stages, adds Bloomberg.